Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-08-01 / Melanoma Res 2021 08;31(4):378-388Immune escape mechanisms and immunotherapy of urothelial bladder cancer
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2021-07-30 / J Clin Transl Res 2021 Aug;7(4):485-500Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro
/in International Publications, Newcastle Disease Virus /von 2021-07-25 / Res Vet Sci 2021 Jul;139:159-165Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2021-07-20 / Gynecol Oncol 2021 Sep;162(3):652-660Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2021-07-19 / Sci Rep 2021 Jul;11(1):14661Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors
/in International Publications, IOZK Veröffentlichungen /von 2021-07-04 / Cancer Immunol Immunother 2021 Jul;A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-06-29 / J Eur Acad Dermatol Venereol 2021 Oct;35(10):1976-1986Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
/in Dendritic Cells, International Publications /von 2021-06-28 / Front Cell Dev Biol 2021;9:686544Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors
/in International Publications, Newcastle Disease Virus /von 2021-06-18 / Saudi J Biol Sci 2021 Oct;28(10):5833-5840Recombinant Newcastle disease virus immunotherapy drives oncolytic effects and durable systemic antitumor immunity
/in International Publications, Newcastle Disease Virus /von 2021-06-17 / Mol Cancer Ther 2021 Jun;Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
/in Dendritic Cells, International Publications, Prostate Cancer, Urothelial Carcinoma /von 2021-06-09 / Vaccines (Basel) 2021 Jun;9(6)Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2021-06-04 / Cancers (Basel) 2021 Jun;13(11)A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors.
/in Dendritic Cells, International Publications /von 2021-06-04 / J Clin Oncol 39, 2021 (suppl 15; abstr e14512)Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
/in Dendritic Cells, International Publications /von 2021-05-20 / Cancers (Basel) 2021 May;13(10)Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials
/in Dendritic Cells, International Publications, Malignant Melanoma, Malignant Pleural Mesothelioma /von 2021-05-19 / Vaccines (Basel) 2021 May;9(5)Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2021-05-14 / Ther Apher Dial 2021 Aug;25(4):415-424Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-05-12 / Cancer Med 2021 Jul;10(13):4302-4311A bibliometric review of oncolytic virus research as a novel approach for cancer therapy
/in International Publications, Newcastle Disease Virus /von 2021-05-12 / Virol J 2021 May;18(1):98Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2021-05-10 / Front Oncol 2021;11:672508MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2021-04-21 / Oncol Lett 2021 Jun;21(6):482